BioInsights - Glimpsing the future of AAV analytical innovation

Glimpsing the future of AAV analytical innovation

Cell & Gene Therapy Insights 2022; 8(9), 999–1004

DOI: 10.18609/cgti.2022.148

Published: 4 September 2022
Wei Zhang

Wei Zhang is a Senior Scientist and heading Downstream Processing Group (DSP) in Bioprocessing Technology Institute (BTI), Agency for Science, Technology and Research (A*STAR) in Singapore. Her team focuses on the downstream process development and product analytics of a variety of novel biotherapeutics, ranging from monoclonal antibodies, bispecific antibodies to viral vectors and nucleic acid therapies. Her team is also committed to work towards intensified and continuous downstream processing. Her team in BTI actively collaborate with dozens of biopharmaceutical companies and bioprocessing solution providers worldwide, including both leading industrial players and local SMEs.